Helius Medical Technologies Files 8-K
Ticker: HSDT · Form: 8-K · Filed: Aug 12, 2024 · CIK: 1610853
| Field | Detail |
|---|---|
| Company | Helius Medical Technologies, Inc. (HSDT) |
| Form Type | 8-K |
| Filed Date | Aug 12, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, financial-condition, operations
TL;DR
Helius Medical Tech filed an 8-K on ops and financials. Details to follow.
AI Summary
On August 12, 2024, Helius Medical Technologies, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, along with financial statements and exhibits. No specific financial figures or operational updates were detailed in the provided excerpt.
Why It Matters
This filing indicates that Helius Medical Technologies is providing an update on its financial condition and operations to the SEC, which is important for investors to monitor company performance.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report for operational and financial updates, with no immediate negative or positive indicators in the provided text.
Key Players & Entities
- HELIUS MEDICAL TECHNOLOGIES, INC. (company) — Registrant
- August 12, 2024 (date) — Date of Report
- 642 Newtown Yardley Road, Suite 100 (address) — Principal Executive Offices
- Newtown, PA 18940 (address) — Principal Executive Offices
FAQ
What specific financial information is being reported by Helius Medical Technologies?
The provided excerpt states the filing concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail specific financial figures.
What is the primary purpose of this 8-K filing?
The primary purpose is to report on the company's results of operations and financial condition, as well as to file financial statements and exhibits.
When was this 8-K report filed?
The report was filed on August 12, 2024.
What is the principal executive office address for Helius Medical Technologies?
The principal executive office is located at 642 Newtown Yardley Road, Suite 100, Newtown, PA 18940.
Does this filing indicate any significant corporate events or changes?
The filing is categorized under 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', suggesting a routine update rather than a major event based on the provided text.
Filing Stats: 561 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-08-12 16:15:30
Filing Documents
- hsdt-20240812x8k.htm (8-K) — 40KB
- hsdt-20240812xex99d1.htm (EX-99.1) — 178KB
- hsdt-20240812x8k001.jpg (GRAPHIC) — 7KB
- hsdt-20240812xex99d1001.jpg (GRAPHIC) — 8KB
- 0001558370-24-011901.txt ( ) — 381KB
- hsdt-20240812.xsd (EX-101.SCH) — 3KB
- hsdt-20240812_lab.xml (EX-101.LAB) — 16KB
- hsdt-20240812_pre.xml (EX-101.PRE) — 10KB
- hsdt-20240812x8k_htm.xml (XML) — 5KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On August 12, 2024, Helius Medical Technologies, Inc. (the "Registrant") issued a press release announcing its financial results for the quarter ended June 30, 2024, as well as information regarding a conference call to discuss these financial results and the Registrant's recent corporate highlights. A copy of this press release is furnished herewith as Exhibit 99.1 to this Current Report and is incorporated herein by reference. In accordance with General Instruction B.2. of Form 8-K, the information in this Item 2.02, and Exhibit 99.1 hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Registrant's filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated August 12, 2024 . 104 Cover Page Interactive Data File (embedded within Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HELIUS MEDICAL TECHNOLOGIES, INC. Dated: August 12, 2024 By: /s/ Jeffrey S. Mathiesen Jeffrey S. Mathiesen Chief Financial Officer and Treasurer 2